|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cuzick J, Powles T, Veronesi U, Forbes J,
Edwards R, Ashley S and Boyle P: Overview of the main outcomes in
breast-cancer prevention trials. Lancet. 361:296–300. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal
therapy for early breast cancer on recurrence and 15-year survival:
An overview of the randomised trials. Lancet. 365:1687–1717. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY,
Zhu Y, Skaar TC, Gomez B, O'Brien K, Wang Y, et al: Antiestrogen
resistance in breast cancer and the role of estrogen receptor
signaling. Oncogene. 22:7316–7339. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lewis JS and Jordan VC: Selective estrogen
receptor modulators (SERMs): Mechanisms of anticarcinogenesis and
drug resistance. Mutat Res. 591:247–263. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang M, Huang O, Zhang X, Xie Z, Shen A,
Liu H, Geng M and Shen K: Curcumin induces cell death and restores
tamoxifen sensitivity in the antiestrogen-resistant breast cancer
cell lines MCF-7/LCC2 and MCF-7/LCC9. Molecules. 18:701–720. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Charalambous C, Pitta CA and Constantinou
AI: Equol enhances tamoxifen's anti-tumor activity by induction of
caspase-mediated apoptosis in MCF-7 breast cancer cells. BMC
Cancer. 13:2382013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mittal A, Tabasum S and Singh RP:
Berberine in combination with doxorubicin suppresses growth of
murine melanoma B16F10 cells in culture and xenograft.
Phytomedicine. 21:340–347. 2014. View Article : Google Scholar
|
|
9
|
Zhao Q, Wang J, Zou MJ, Hu R, Zhao L,
Qiang L, Rong JJ, You QD and Guo QL: Wogonin potentiates the
antitumor effects of low dose 5-fluorouracil against gastric cancer
through induction of apoptosis by down-regulation of NF-kappaB and
regulation of its metabolism. Toxicol Lett. 197:201–210. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Notarbartolo M, Poma P, Perri D, Dusonchet
L, Cervello M and D'Alessandro N: Antitumor effects of curcumin,
alone or in combination with cisplatin or doxorubicin, on human
hepatic cancer cells. Analysis of their possible relationship to
changes in NF-kB activation levels and in IAP gene expression.
Cancer Lett. 224:53–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wen CJ, Wu LX, Fu LJ, Yu J, Zhang YW,
Zhang X and Zhou HH: Genomic screening for targets regulated by
berberine in breast cancer cells. Asian Pac J Cancer Prev.
14:6089–6094. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Liu Q, Liu Z, Li B, Sun Z, Zhou H,
Zhang X, Gong Y and Shao C: Berberine, a genotoxic alkaloid,
induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. Mutat
Res. 734:20–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu B, Hu M, Liu K and Peng J: Cytotoxicity
of berberine on human cervical carcinoma HeLa cells through
mitochondria, death receptor and MAPK pathways, and in-silico
drug-target prediction. Toxicol In Vitro. 24:1482–1490. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu B, Zhao J, Xu L, Xu Y, Wang X and Peng
J: Identification of molecular target proteins in berberine-treated
cervix adenocarcinoma HeLa cells by proteomic and bioinformatic
analyses. Phytother Res. 26:646–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Youn MJ, So HS, Cho HJ, Kim Y, Lee JH,
Sohn JS, Kim YK, Chung SY and Park R: Berberine, a natural product,
combined with cisplatin enhanced apoptosis through a
mitochondria/caspase-mediated pathway in HeLa cells. Biol Pharm
Bull. 31:789–795. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin TH, Kuo HC, Chou FP and Lu FJ:
Berberine enhances inhi-bition of glioma tumor cell migration and
invasiveness mediated by arsenic trioxide. BMC Cancer. 8:582008.
View Article : Google Scholar
|
|
17
|
Fan LX, Liu CM, Gao AH, Zhou YB and Li J:
Berberine combined with 2-deoxy-d-glucose synergistically enhances
cancer cell proliferation inhibition via energy depletion and
unfolded protein response disruption. Biochim Biophys Acta.
1830:5175–5183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Patil JB, Kim J and Jayaprakasha GK:
Berberine induces apoptosis in breast cancer cells (MCF-7) through
mitochondrial-dependent pathway. Eur J Pharmacol. 645:70–78. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abukhdeir AM, Vitolo MI, Argani P, De
Marzo AM, Karakas B, Konishi H, Gustin JP, Lauring J, Garay JP,
Pendleton C, et al: Tamoxifen-stimulated growth of breast cancer
due to p21 loss. Proc Natl Acad Sci USA. 105:288–293. 2008.
View Article : Google Scholar :
|
|
20
|
Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F,
Yang Q, Gao G, Gong Y and Shao C: Berberine induces p53-dependent
cell cycle arrest and apoptosis of human osteosarcoma cells by
inflicting DNA damage. Mutat Res. 662:75–83. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Larsen MS, Bjerre K, Giobbie-Hurder A,
Lænkholm AV, Henriksen KL, Ejlertsen B, Lykkesfeldt AE and
Rasmussen BB: Prognostic value of Bcl-2 in two independent
populations of estrogen receptor positive breast cancer patients
treated with adjuvant endocrine therapy. Acta Oncol. 51:781–789.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lv L, Zheng L, Dong D, Xu L, Yin L, Xu Y,
Qi Y, Han X and Peng J: Dioscin, a natural steroid saponin, induces
apoptosis and DNA damage through reactive oxygen species: A
potential new drug for treatment of glioblastoma multiforme. Food
Chem Toxicol. 59:657–669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Callagy GM, Pharoah PD, Pinder SE, Hsu FD,
Nielsen TO, Ragaz J, Ellis IO, Huntsman D and Caldas C: Bcl-2 is a
prognostic marker in breast cancer independently of the Nottingham
prognostic index. Clin Cancer Res. 12:2468–2475. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cardoso F, Paesmans M, Larsimont D,
Durbecq V, Bernard-Marty C, Rouas G, Dolci S, Sotiriou C, Piccart
MJ and Di Leo A: Potential predictive value of Bcl-2 for response
to tamoxifen in the adjuvant setting of node-positive breast
cancer. Clin Breast Cancer. 5:364–369. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu C, Kong X, Wang H, Zhang N, Kong X,
Ding X, Li X and Yang Q: MTDH mediates estrogen-independent growth
and tamoxifen resistance by down-regulating PTEN in MCF-7 breast
cancer cells. Cell Physiol Biochem. 33:1557–1567. 2014. View Article : Google Scholar : PubMed/NCBI
|
